News Archives - Page 157 of 738

MondayNov 27, 2023 9:45 am

D-Wave Quantum Inc. (NYSE: QBTS) Announces Third-Quarter Financial Highlights, Voices Support for Expanded National Quantum Initiative

D-Wave third-quarter revenue grew by 51% year-over-year D-Wave’s third quarter bookings increased by 53% year-over-year, representing the company’s sixth consecutive quarter of year-over-year booking growth, while the first three quarters bookings increased by 125% when compared to the year earlier period CEO Dr. Alan Baratz recently met with Members of Congress to urge them to support the reauthorization of the National Quantum Initiative and ensure that it was expanded to encompass all quantum computing technologies D-Wave Quantum (NYSE: QBTS), a leader in commercial quantum computing systems, software, and services, recently announced financial results for its fiscal third quarter, which ended…

MondayNov 27, 2023 9:00 am

Software Effective Solutions Corp. (SFWJ) Is ‘One to Watch’

MedCana announced in May 2023 full-scale production of non-THC cannabis for export to Europe The company earlier in 2023 commenced construction of crop production infrastructure at sites in Central and South America MedCana has engaged in talks with the government of Argentina about starting production in that country The company in 2023 acquired the assets of Tokan Corp., including an ERP software platform for the cannabis industry Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ) is a global infrastructure and holding company in the cannabis industry. MedCana currently has five companies focused on pharmaceutical cannabis production, as well a software company…

WednesdayNov 22, 2023 9:45 am

Genprex Inc. (NASDAQ: GNPX) Granted Orphan Drug Designation in Small Cell Lung Cancer by FDA, Presented Data at Two October Events Focused on Lung Cancer

Genprex was granted orphan drug designation by the FDA earlier this year for development of REQORSA combined with Tecentriq in small cell lung cancer Use of REQORSA combined with Tecentriq is the subject of Genprex’s upcoming Acclaim-3 clinical trial Genprex took part in two events in October – the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics; and Genprex’s own hosted event, a Virtual Key Opinion Leaders on Bringing Gene Therapy to the Fight Against Lung Cancers Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients living with cancer and diabetes, was…

WednesdayNov 22, 2023 9:00 am

Clene Inc. (NASDAQ: CLNN) Capitalizing on the Promising Chemical and Therapeutic Properties of Nanocrystals to Address High Unmet Medical Needs

Clene is focused on developing and commercializing novel clean-surfaced nanotechnology (“CSN(R)”) therapeutics The company utilizes an electro-crystallization nanotherapeutics platform, which results in nanocrystals that exhibit catalytic activities multiple times higher than numerous other commercially available nanoparticles that the company has comparatively evaluated Clene is focusing on central nervous system (“CNS”) disorders like amyotrophic lateral sclerosis (“ALS”), multiple sclerosis (“MS”), and Parkinson’s disease (“PD”) Its lead investigational product, CNM-Au8(R), has so far demonstrated a good safety and tolerability profile, with Phase 2 trials suggesting efficacy in ALS patients Nanotechnology has attracted a great deal of the scientific community’s attention thanks to…

TuesdayNov 21, 2023 10:30 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Makes Visionary Pitch for Domestic REE Supply Chain at Fall Mining Showcase 2023

Rare earth element (“REE”) enterprise Ucore Rare Metals Inc. is developing an innovative separation technology for REEs critical to modern computer technologies The company is preparing to advance the operational machinery being used to demonstrate Ucore’s proprietary RapidSX(TM) solution side-by-side with conventional separation technology, designing a similar commercial operation that will begin commissioning next year in Louisiana China currently dominates the global market for mining, processing, and product creation for REEs, leading to American concerns about vulnerability to price and supply policies controlled by China’s government Ucore has received a $4 million award from the U.S. Department of Defense to…

TuesdayNov 21, 2023 9:45 am

Longeveron Inc. (NASDAQ: LGVN) Encouraged by Positive Results from Phase 2a Trial in Patients with Mild AD; Explores Paths Forward for the Development of Lomecel-B(TM)

Longeveron recently released topline results from its Phase 2a trial evaluating Lomecel-B(TM) as a potential treatment for mild AD The study met its primary safety endpoint across all four study groups and showed positive and statistically significant results in secondary endpoint involving the Composite Alzheimer’s Disease Score (“CADS”) for Lomecel-B(TM) and components of the CADS The positive results are expected to form the basis for further development of Lomecel-B(TM) as a potential treatment for mild AD Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions for which there is an unmet medical need, announced…

TuesdayNov 21, 2023 9:00 am

Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GTD0) Offering SekurMessenger, its Encrypted Messenger App, Amid SEC FINRA Violations Crackdown

Sekur, a cybersecurity and internet privacy provider of Swiss-hosted solutions for secure communications and secure data management, is pushing its SekurMessenger amid SEC crackdowns on Wall Street The app provides end-to-end encryption, proprietary VirtualVaults, and HelixTech that ensure conversations are secure while also maintaining privacy It allows companies on Wall Street to meet the FINRA communication compliance requirements while giving them the overall peace of mind that comes with guaranteed security and encryption With this offering, Sekur looks to carve out a significant market share while also asserting itself as a leader in its segment Sekur Private Data (CSE: SKUR)…

MondayNov 20, 2023 11:15 am

SuperCom Ltd. (NASDAQ: SPCB) Announces Extended Collaboration with Romanian Government Following Third $3.4 Million Order

SuperCom, a global leading provider of traditional and digital identity solutions, just announced its latest order from the Romanian government to the tune of $3.4 million SuperCom will help Romania’s Ministry of Interior to bolster its EM project, based on its PureSecurity Suite, covering domestic violence monitoring, GPS tracking of offenders, as well as home detection monitoring Deliveries are set to be met by the end of Q4 2023, and SuperCom’s management is optimistic that the order will boost the company’s overall value proposition and lead to many more orders down the line SuperCom (NASDAQ: SPCB), a leading global provider…

MondayNov 20, 2023 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking to Generate Sizable License Revenue from IP Growth, Expanding Patent Suite

Lexaria, a global innovator in drug delivery platforms, has, since 2014, continuously worked on its patented DehydraTECH(TM) drug delivery technology The technology has demonstrated overall effectiveness in enhanced delivery of fat-soluble molecules through the human gastrointestinal system, as affirmed by clinical testing This overall effectiveness and push for its development has earned Lexaria 37 granted patents globally, with many patents pending The company is constantly enhancing its patent portfolio, since granted patents can support an increase in licensing revenue Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is eyeing growth in license revenue from its intellectual property…

MondayNov 20, 2023 9:45 am

Turbo Energy S.A. (NASDAQ: TURB) Is ‘One to Watch’

Turbo Energy in September 2023 announced its successful debut on the Nasdaq stock exchange The company operates as a subsidiary of Umbrella Solar Investment S.A. Turbo Energy’s total revenue for the year ended December 31, 2022, increased by 82% year-over-year to €31,148,676 (approximately $33,321,219) In October 2023, the company was awarded a software patent in Spain related to its flagship Sunbox product Turbo Energy (NASDAQ: TURB) designs, develops and distributes equipment for the generation, management and storage of photovoltaic energy in Spain, Europe and internationally. Turbo Energy’s products include lithium-ion batteries and inverters. Additionally, the company recently launched its flagship…

Site Search

Company Search

Category: News